OrthoPediatrics Corp. (KIDS) vs Prime Medicine, Inc. (PRME)

A side-by-side comparison of OrthoPediatrics Corp. and Prime Medicine, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KIDS vs PRME

growth of $100 · dividends reinvested · last 4y
KIDS -47.8% (-15.0%/yr)PRME -79.1% (-32.4%/yr)KIDS compounded faster over this window
050100Start $1002023202420252026$52$21
KIDS PRME

KIDS vs PRME: by the numbers

  • •PRME is the larger company ($632M vs $583M market cap).
  • •Both run net losses; KIDS's is the smaller (-15.72% vs -4613.11% net margin).
  • •KIDS grew revenue faster over the past five years (23.14% vs -2.32% CAGR).

Metrics side by side

Valuation

MetricKIDSPRME
P/S ratio2.31155.21
P/B ratio1.7015.88

Profitability

MetricKIDSPRME
Gross margin73.65%-58.05%
Operating margin-9.01%-4498.06%
Net margin-15.72%-4613.11%
ROE-11.56%-471.98%
ROIC-4.97%-90.42%

Growth (annualized)

MetricKIDSPRME
Revenue CAGR (5Y)23.14%-2.32%
Total return CAGR (5Y)-18.40%N/A

Frequently asked

Which has grown faster, KIDS or PRME?
Over the past five years, KIDS grew revenue faster — KIDS at a 23.14% CAGR versus PRME at -2.32%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.